人工臓器&バイオニックインプラントの世界市場2023年:人工腎臓、人工心臓&補助人工心臓、人工内耳、人工肺、人工肝臓、人工膵臓、バイオニックハンド&人工装具、その他

■ 英語タイトル:Global Artificial Organs and Bionic Implants Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート(データ管理コード:QYR23MA7636)■ 発行会社/調査会社:QYResearch
■ 商品コード:QYR23MA7636
■ 発行日:2023年3月
■ 調査対象地域:グローバル
■ 産業分野:医療機器
■ ページ数:115
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後2-3営業日)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,900 ⇒換算¥440,800見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD4,350 ⇒換算¥661,200見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD5,800 ⇒換算¥881,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[人工臓器&バイオニックインプラントの世界市場2023年:人工腎臓、人工心臓&補助人工心臓、人工内耳、人工肺、人工肝臓、人工膵臓、バイオニックハンド&人工装具、その他]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

当調査資料は人工臓器&バイオニックインプラントのグローバル市場について調査・分析し、世界の人工臓器&バイオニックインプラント市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析(人工腎臓、人工心臓&補助人工心臓、人工内耳、人工肺、人工肝臓、人工膵臓、バイオニックハンド&人工装具、その他)、用途別セグメント分析(商品化、臨床研究)、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Fresenius Medical Care、Cochlear、Abiomed、ABBOTT、Baxter、B.Braun、Asahi Kasei Corporation、Nipro、MED-EL、Toray Medical、Sonova、Medtronic、Getinge (Maquet)、William Demant、LivaNova (Sorin)、Terumo、Hangzhou Nurotron、Syncardia、CorWave、Listent Medical、Evaheart、Open Bionics、OYMotion Technologies、Mobius Bionicsなどが含まれています。人工臓器&バイオニックインプラントのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX%です。新型コロナとロシア・ウクライナ戦争の影響は、人工臓器&バイオニックインプラント市場規模を算出する際に考慮しました。

・人工臓器&バイオニックインプラント市場の概要
- 人工臓器&バイオニックインプラントの種類別セグメント
- 世界の人工臓器&バイオニックインプラント市場規模:タイプ別分析(人工腎臓、人工心臓&補助人工心臓、人工内耳、人工肺、人工肝臓、人工膵臓、バイオニックハンド&人工装具、その他)
- 人工臓器&バイオニックインプラントの用途別セグメント
- 世界の人工臓器&バイオニックインプラント市場規模:用途別分析(商品化、臨床研究)
- 世界の人工臓器&バイオニックインプラント市場規模予測(2018年-2029年)

・人工臓器&バイオニックインプラント市場の成長トレンド
- 人工臓器&バイオニックインプラントの地域別市場規模(2018年-2029年)
- 人工臓器&バイオニックインプラント市場ダイナミクス
- 人工臓器&バイオニックインプラントの業界動向
- 人工臓器&バイオニックインプラント市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M&A動向

・種類別セグメント:人工腎臓、人工心臓&補助人工心臓、人工内耳、人工肺、人工肝臓、人工膵臓、バイオニックハンド&人工装具、その他
- 世界の人工臓器&バイオニックインプラントのタイプ別市場規模(2018年-2023年)
- 世界の人工臓器&バイオニックインプラントのタイプ別市場規模(2024年-2029年)

・用途別セグメント:商品化、臨床研究
- 世界の人工臓器&バイオニックインプラントの用途別市場規模(2018年-2023年)
- 世界の人工臓器&バイオニックインプラントの用途別市場規模(2024年-2029年)

・人工臓器&バイオニックインプラントの地域別市場規模
- 北米の人工臓器&バイオニックインプラント市場規模(2018年-2029年)
- 米国の人工臓器&バイオニックインプラント市場規模(2018年-2029年)
- ヨーロッパの人工臓器&バイオニックインプラント市場規模(2018年-2029年)
- アジア太平洋の人工臓器&バイオニックインプラント市場規模(2018年-2029年)
- 中国の人工臓器&バイオニックインプラント市場規模(2018年-2029年)
- 日本の人工臓器&バイオニックインプラント市場規模(2018年-2029年)
- 韓国の人工臓器&バイオニックインプラント市場規模(2018年-2029年)
- インドの人工臓器&バイオニックインプラント市場規模(2018年-2029年)
- オーストラリアの人工臓器&バイオニックインプラント市場規模(2018年-2029年)
- 中南米の人工臓器&バイオニックインプラント市場規模(2018年-2029年)
- 中東・アフリカの人工臓器&バイオニックインプラント市場規模(2018年-2029年)

・主要企業のプロファイル:企業情報、事業概要、売上、動向
Fresenius Medical Care、Cochlear、Abiomed、ABBOTT、Baxter、B.Braun、Asahi Kasei Corporation、Nipro、MED-EL、Toray Medical、Sonova、Medtronic、Getinge (Maquet)、William Demant、LivaNova (Sorin)、Terumo、Hangzhou Nurotron、Syncardia、CorWave、Listent Medical、Evaheart、Open Bionics、OYMotion Technologies、Mobius Bionics

・アナリストの観点/結論

・調査手法と情報源

An artificial organ is a human made organ device or tissue that is implanted or integrated into a human — interfacing with living tissue — to replace a natural organ, to duplicate or augment a specific function or functions so the patient may return to a normal life as soon as possible. Bionic implants refer to electronic or mechatronic parts that augment or restore physical functionality to a differently-abled person.
Highlights
The global Artificial Organs and Bionic Implants market was valued at US$ 9830 million in 2022 and is anticipated to reach US$ 15080 million by 2029, witnessing a CAGR of 7.4% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is the largest market of Artificial Organs And Bionic Implants, with a share about 45%, followed by Europe and China, both have a share about 50 percent. Global top 5 companies include Fresenius Medical Care, Cochlear, Abiomed, ABBOTT and Baxter, they hold a share over 50%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Artificial Organs and Bionic Implants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Organs and Bionic Implants.
The Artificial Organs and Bionic Implants market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Artificial Organs and Bionic Implants market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Organs and Bionic Implants companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Fresenius Medical Care
Cochlear
Abiomed
ABBOTT
Baxter
B.Braun
Asahi Kasei Corporation
Nipro
MED-EL
Toray Medical
Sonova
Medtronic
Getinge (Maquet)
William Demant
LivaNova (Sorin)
Terumo
Hangzhou Nurotron
Syncardia
CorWave
Listent Medical
Evaheart
Open Bionics
OYMotion Technologies
Mobius Bionics
Segment by Type
Artificial Kidney
Artificial Heart & Ventricular Assist Device
Cochlear Implant
Artificial Lung
Artificial Liver
Artificial Pancreas
Bionic Hands & Prosthetics
Others
Segment by Application
Commercialize
Clinical Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Organs and Bionic Implants companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

世界の市場調査レポート販売サイト(H&Iグローバルリサーチ株式会社運営)
*** レポート目次(コンテンツ)***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Organs and Bionic Implants Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Artificial Kidney
1.2.3 Artificial Heart & Ventricular Assist Device
1.2.4 Cochlear Implant
1.2.5 Artificial Lung
1.2.6 Artificial Liver
1.2.7 Artificial Pancreas
1.2.8 Bionic Hands & Prosthetics
1.2.9 Others
1.3 Market by Application
1.3.1 Global Artificial Organs and Bionic Implants Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Commercialize
1.3.3 Clinical Research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Organs and Bionic Implants Market Perspective (2018-2029)
2.2 Artificial Organs and Bionic Implants Growth Trends by Region
2.2.1 Global Artificial Organs and Bionic Implants Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Artificial Organs and Bionic Implants Historic Market Size by Region (2018-2023)
2.2.3 Artificial Organs and Bionic Implants Forecasted Market Size by Region (2024-2029)
2.3 Artificial Organs and Bionic Implants Market Dynamics
2.3.1 Artificial Organs and Bionic Implants Industry Trends
2.3.2 Artificial Organs and Bionic Implants Market Drivers
2.3.3 Artificial Organs and Bionic Implants Market Challenges
2.3.4 Artificial Organs and Bionic Implants Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Organs and Bionic Implants Players by Revenue
3.1.1 Global Top Artificial Organs and Bionic Implants Players by Revenue (2018-2023)
3.1.2 Global Artificial Organs and Bionic Implants Revenue Market Share by Players (2018-2023)
3.2 Global Artificial Organs and Bionic Implants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artificial Organs and Bionic Implants Revenue
3.4 Global Artificial Organs and Bionic Implants Market Concentration Ratio
3.4.1 Global Artificial Organs and Bionic Implants Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Organs and Bionic Implants Revenue in 2022
3.5 Artificial Organs and Bionic Implants Key Players Head office and Area Served
3.6 Key Players Artificial Organs and Bionic Implants Product Solution and Service
3.7 Date of Enter into Artificial Organs and Bionic Implants Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Organs and Bionic Implants Breakdown Data by Type
4.1 Global Artificial Organs and Bionic Implants Historic Market Size by Type (2018-2023)
4.2 Global Artificial Organs and Bionic Implants Forecasted Market Size by Type (2024-2029)
5 Artificial Organs and Bionic Implants Breakdown Data by Application
5.1 Global Artificial Organs and Bionic Implants Historic Market Size by Application (2018-2023)
5.2 Global Artificial Organs and Bionic Implants Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Artificial Organs and Bionic Implants Market Size (2018-2029)
6.2 North America Artificial Organs and Bionic Implants Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Artificial Organs and Bionic Implants Market Size by Country (2018-2023)
6.4 North America Artificial Organs and Bionic Implants Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Organs and Bionic Implants Market Size (2018-2029)
7.2 Europe Artificial Organs and Bionic Implants Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Artificial Organs and Bionic Implants Market Size by Country (2018-2023)
7.4 Europe Artificial Organs and Bionic Implants Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Organs and Bionic Implants Market Size (2018-2029)
8.2 Asia-Pacific Artificial Organs and Bionic Implants Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Artificial Organs and Bionic Implants Market Size by Region (2018-2023)
8.4 Asia-Pacific Artificial Organs and Bionic Implants Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Organs and Bionic Implants Market Size (2018-2029)
9.2 Latin America Artificial Organs and Bionic Implants Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Artificial Organs and Bionic Implants Market Size by Country (2018-2023)
9.4 Latin America Artificial Organs and Bionic Implants Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Organs and Bionic Implants Market Size (2018-2029)
10.2 Middle East & Africa Artificial Organs and Bionic Implants Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Artificial Organs and Bionic Implants Market Size by Country (2018-2023)
10.4 Middle East & Africa Artificial Organs and Bionic Implants Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Fresenius Medical Care
11.1.1 Fresenius Medical Care Company Detail
11.1.2 Fresenius Medical Care Business Overview
11.1.3 Fresenius Medical Care Artificial Organs and Bionic Implants Introduction
11.1.4 Fresenius Medical Care Revenue in Artificial Organs and Bionic Implants Business (2018-2023)
11.1.5 Fresenius Medical Care Recent Development
11.2 Cochlear
11.2.1 Cochlear Company Detail
11.2.2 Cochlear Business Overview
11.2.3 Cochlear Artificial Organs and Bionic Implants Introduction
11.2.4 Cochlear Revenue in Artificial Organs and Bionic Implants Business (2018-2023)
11.2.5 Cochlear Recent Development
11.3 Abiomed
11.3.1 Abiomed Company Detail
11.3.2 Abiomed Business Overview
11.3.3 Abiomed Artificial Organs and Bionic Implants Introduction
11.3.4 Abiomed Revenue in Artificial Organs and Bionic Implants Business (2018-2023)
11.3.5 Abiomed Recent Development
11.4 ABBOTT
11.4.1 ABBOTT Company Detail
11.4.2 ABBOTT Business Overview
11.4.3 ABBOTT Artificial Organs and Bionic Implants Introduction
11.4.4 ABBOTT Revenue in Artificial Organs and Bionic Implants Business (2018-2023)
11.4.5 ABBOTT Recent Development
11.5 Baxter
11.5.1 Baxter Company Detail
11.5.2 Baxter Business Overview
11.5.3 Baxter Artificial Organs and Bionic Implants Introduction
11.5.4 Baxter Revenue in Artificial Organs and Bionic Implants Business (2018-2023)
11.5.5 Baxter Recent Development
11.6 B.Braun
11.6.1 B.Braun Company Detail
11.6.2 B.Braun Business Overview
11.6.3 B.Braun Artificial Organs and Bionic Implants Introduction
11.6.4 B.Braun Revenue in Artificial Organs and Bionic Implants Business (2018-2023)
11.6.5 B.Braun Recent Development
11.7 Asahi Kasei Corporation
11.7.1 Asahi Kasei Corporation Company Detail
11.7.2 Asahi Kasei Corporation Business Overview
11.7.3 Asahi Kasei Corporation Artificial Organs and Bionic Implants Introduction
11.7.4 Asahi Kasei Corporation Revenue in Artificial Organs and Bionic Implants Business (2018-2023)
11.7.5 Asahi Kasei Corporation Recent Development
11.8 Nipro
11.8.1 Nipro Company Detail
11.8.2 Nipro Business Overview
11.8.3 Nipro Artificial Organs and Bionic Implants Introduction
11.8.4 Nipro Revenue in Artificial Organs and Bionic Implants Business (2018-2023)
11.8.5 Nipro Recent Development
11.9 MED-EL
11.9.1 MED-EL Company Detail
11.9.2 MED-EL Business Overview
11.9.3 MED-EL Artificial Organs and Bionic Implants Introduction
11.9.4 MED-EL Revenue in Artificial Organs and Bionic Implants Business (2018-2023)
11.9.5 MED-EL Recent Development
11.10 Toray Medical
11.10.1 Toray Medical Company Detail
11.10.2 Toray Medical Business Overview
11.10.3 Toray Medical Artificial Organs and Bionic Implants Introduction
11.10.4 Toray Medical Revenue in Artificial Organs and Bionic Implants Business (2018-2023)
11.10.5 Toray Medical Recent Development
11.11 Sonova
11.11.1 Sonova Company Detail
11.11.2 Sonova Business Overview
11.11.3 Sonova Artificial Organs and Bionic Implants Introduction
11.11.4 Sonova Revenue in Artificial Organs and Bionic Implants Business (2018-2023)
11.11.5 Sonova Recent Development
11.12 Medtronic
11.12.1 Medtronic Company Detail
11.12.2 Medtronic Business Overview
11.12.3 Medtronic Artificial Organs and Bionic Implants Introduction
11.12.4 Medtronic Revenue in Artificial Organs and Bionic Implants Business (2018-2023)
11.12.5 Medtronic Recent Development
11.13 Getinge (Maquet)
11.13.1 Getinge (Maquet) Company Detail
11.13.2 Getinge (Maquet) Business Overview
11.13.3 Getinge (Maquet) Artificial Organs and Bionic Implants Introduction
11.13.4 Getinge (Maquet) Revenue in Artificial Organs and Bionic Implants Business (2018-2023)
11.13.5 Getinge (Maquet) Recent Development
11.14 William Demant
11.14.1 William Demant Company Detail
11.14.2 William Demant Business Overview
11.14.3 William Demant Artificial Organs and Bionic Implants Introduction
11.14.4 William Demant Revenue in Artificial Organs and Bionic Implants Business (2018-2023)
11.14.5 William Demant Recent Development
11.15 LivaNova (Sorin)
11.15.1 LivaNova (Sorin) Company Detail
11.15.2 LivaNova (Sorin) Business Overview
11.15.3 LivaNova (Sorin) Artificial Organs and Bionic Implants Introduction
11.15.4 LivaNova (Sorin) Revenue in Artificial Organs and Bionic Implants Business (2018-2023)
11.15.5 LivaNova (Sorin) Recent Development
11.16 Terumo
11.16.1 Terumo Company Detail
11.16.2 Terumo Business Overview
11.16.3 Terumo Artificial Organs and Bionic Implants Introduction
11.16.4 Terumo Revenue in Artificial Organs and Bionic Implants Business (2018-2023)
11.16.5 Terumo Recent Development
11.17 Hangzhou Nurotron
11.17.1 Hangzhou Nurotron Company Detail
11.17.2 Hangzhou Nurotron Business Overview
11.17.3 Hangzhou Nurotron Artificial Organs and Bionic Implants Introduction
11.17.4 Hangzhou Nurotron Revenue in Artificial Organs and Bionic Implants Business (2018-2023)
11.17.5 Hangzhou Nurotron Recent Development
11.18 Syncardia
11.18.1 Syncardia Company Detail
11.18.2 Syncardia Business Overview
11.18.3 Syncardia Artificial Organs and Bionic Implants Introduction
11.18.4 Syncardia Revenue in Artificial Organs and Bionic Implants Business (2018-2023)
11.18.5 Syncardia Recent Development
11.19 CorWave
11.19.1 CorWave Company Detail
11.19.2 CorWave Business Overview
11.19.3 CorWave Artificial Organs and Bionic Implants Introduction
11.19.4 CorWave Revenue in Artificial Organs and Bionic Implants Business (2018-2023)
11.19.5 CorWave Recent Development
11.20 Listent Medical
11.20.1 Listent Medical Company Detail
11.20.2 Listent Medical Business Overview
11.20.3 Listent Medical Artificial Organs and Bionic Implants Introduction
11.20.4 Listent Medical Revenue in Artificial Organs and Bionic Implants Business (2018-2023)
11.20.5 Listent Medical Recent Development
11.21 Evaheart
11.21.1 Evaheart Company Detail
11.21.2 Evaheart Business Overview
11.21.3 Evaheart Artificial Organs and Bionic Implants Introduction
11.21.4 Evaheart Revenue in Artificial Organs and Bionic Implants Business (2018-2023)
11.21.5 Evaheart Recent Development
11.22 Open Bionics
11.22.1 Open Bionics Company Detail
11.22.2 Open Bionics Business Overview
11.22.3 Open Bionics Artificial Organs and Bionic Implants Introduction
11.22.4 Open Bionics Revenue in Artificial Organs and Bionic Implants Business (2018-2023)
11.22.5 Open Bionics Recent Development
11.23 OYMotion Technologies
11.23.1 OYMotion Technologies Company Detail
11.23.2 OYMotion Technologies Business Overview
11.23.3 OYMotion Technologies Artificial Organs and Bionic Implants Introduction
11.23.4 OYMotion Technologies Revenue in Artificial Organs and Bionic Implants Business (2018-2023)
11.23.5 OYMotion Technologies Recent Development
11.24 Mobius Bionics
11.24.1 Mobius Bionics Company Detail
11.24.2 Mobius Bionics Business Overview
11.24.3 Mobius Bionics Artificial Organs and Bionic Implants Introduction
11.24.4 Mobius Bionics Revenue in Artificial Organs and Bionic Implants Business (2018-2023)
11.24.5 Mobius Bionics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Artificial Organs and Bionic Implants Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Artificial Kidney
Table 3. Key Players of Artificial Heart & Ventricular Assist Device
Table 4. Key Players of Cochlear Implant
Table 5. Key Players of Artificial Lung
Table 6. Key Players of Artificial Liver
Table 7. Key Players of Artificial Pancreas
Table 8. Key Players of Bionic Hands & Prosthetics
Table 9. Key Players of Others
Table 10. Global Artificial Organs and Bionic Implants Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 11. Global Artificial Organs and Bionic Implants Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 12. Global Artificial Organs and Bionic Implants Market Size by Region (2018-2023) & (US$ Million)
Table 13. Global Artificial Organs and Bionic Implants Market Share by Region (2018-2023)
Table 14. Global Artificial Organs and Bionic Implants Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 15. Global Artificial Organs and Bionic Implants Market Share by Region (2024-2029)
Table 16. Artificial Organs and Bionic Implants Market Trends
Table 17. Artificial Organs and Bionic Implants Market Drivers
Table 18. Artificial Organs and Bionic Implants Market Challenges
Table 19. Artificial Organs and Bionic Implants Market Restraints
Table 20. Global Artificial Organs and Bionic Implants Revenue by Players (2018-2023) & (US$ Million)
Table 21. Global Artificial Organs and Bionic Implants Market Share by Players (2018-2023)
Table 22. Global Top Artificial Organs and Bionic Implants Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Organs and Bionic Implants as of 2022)
Table 23. Ranking of Global Top Artificial Organs and Bionic Implants Companies by Revenue (US$ Million) in 2022
Table 24. Global 5 Largest Players Market Share by Artificial Organs and Bionic Implants Revenue (CR5 and HHI) & (2018-2023)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Artificial Organs and Bionic Implants Product Solution and Service
Table 27. Date of Enter into Artificial Organs and Bionic Implants Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Artificial Organs and Bionic Implants Market Size by Type (2018-2023) & (US$ Million)
Table 30. Global Artificial Organs and Bionic Implants Revenue Market Share by Type (2018-2023)
Table 31. Global Artificial Organs and Bionic Implants Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 32. Global Artificial Organs and Bionic Implants Revenue Market Share by Type (2024-2029)
Table 33. Global Artificial Organs and Bionic Implants Market Size by Application (2018-2023) & (US$ Million)
Table 34. Global Artificial Organs and Bionic Implants Revenue Market Share by Application (2018-2023)
Table 35. Global Artificial Organs and Bionic Implants Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 36. Global Artificial Organs and Bionic Implants Revenue Market Share by Application (2024-2029)
Table 37. North America Artificial Organs and Bionic Implants Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Artificial Organs and Bionic Implants Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Artificial Organs and Bionic Implants Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Artificial Organs and Bionic Implants Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Europe Artificial Organs and Bionic Implants Market Size by Country (2018-2023) & (US$ Million)
Table 42. Europe Artificial Organs and Bionic Implants Market Size by Country (2024-2029) & (US$ Million)
Table 43. Asia-Pacific Artificial Organs and Bionic Implants Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 44. Asia-Pacific Artificial Organs and Bionic Implants Market Size by Region (2018-2023) & (US$ Million)
Table 45. Asia-Pacific Artificial Organs and Bionic Implants Market Size by Region (2024-2029) & (US$ Million)
Table 46. Latin America Artificial Organs and Bionic Implants Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Latin America Artificial Organs and Bionic Implants Market Size by Country (2018-2023) & (US$ Million)
Table 48. Latin America Artificial Organs and Bionic Implants Market Size by Country (2024-2029) & (US$ Million)
Table 49. Middle East & Africa Artificial Organs and Bionic Implants Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 50. Middle East & Africa Artificial Organs and Bionic Implants Market Size by Country (2018-2023) & (US$ Million)
Table 51. Middle East & Africa Artificial Organs and Bionic Implants Market Size by Country (2024-2029) & (US$ Million)
Table 52. Fresenius Medical Care Company Detail
Table 53. Fresenius Medical Care Business Overview
Table 54. Fresenius Medical Care Artificial Organs and Bionic Implants Product
Table 55. Fresenius Medical Care Revenue in Artificial Organs and Bionic Implants Business (2018-2023) & (US$ Million)
Table 56. Fresenius Medical Care Recent Development
Table 57. Cochlear Company Detail
Table 58. Cochlear Business Overview
Table 59. Cochlear Artificial Organs and Bionic Implants Product
Table 60. Cochlear Revenue in Artificial Organs and Bionic Implants Business (2018-2023) & (US$ Million)
Table 61. Cochlear Recent Development
Table 62. Abiomed Company Detail
Table 63. Abiomed Business Overview
Table 64. Abiomed Artificial Organs and Bionic Implants Product
Table 65. Abiomed Revenue in Artificial Organs and Bionic Implants Business (2018-2023) & (US$ Million)
Table 66. Abiomed Recent Development
Table 67. ABBOTT Company Detail
Table 68. ABBOTT Business Overview
Table 69. ABBOTT Artificial Organs and Bionic Implants Product
Table 70. ABBOTT Revenue in Artificial Organs and Bionic Implants Business (2018-2023) & (US$ Million)
Table 71. ABBOTT Recent Development
Table 72. Baxter Company Detail
Table 73. Baxter Business Overview
Table 74. Baxter Artificial Organs and Bionic Implants Product
Table 75. Baxter Revenue in Artificial Organs and Bionic Implants Business (2018-2023) & (US$ Million)
Table 76. Baxter Recent Development
Table 77. B.Braun Company Detail
Table 78. B.Braun Business Overview
Table 79. B.Braun Artificial Organs and Bionic Implants Product
Table 80. B.Braun Revenue in Artificial Organs and Bionic Implants Business (2018-2023) & (US$ Million)
Table 81. B.Braun Recent Development
Table 82. Asahi Kasei Corporation Company Detail
Table 83. Asahi Kasei Corporation Business Overview
Table 84. Asahi Kasei Corporation Artificial Organs and Bionic Implants Product
Table 85. Asahi Kasei Corporation Revenue in Artificial Organs and Bionic Implants Business (2018-2023) & (US$ Million)
Table 86. Asahi Kasei Corporation Recent Development
Table 87. Nipro Company Detail
Table 88. Nipro Business Overview
Table 89. Nipro Artificial Organs and Bionic Implants Product
Table 90. Nipro Revenue in Artificial Organs and Bionic Implants Business (2018-2023) & (US$ Million)
Table 91. Nipro Recent Development
Table 92. MED-EL Company Detail
Table 93. MED-EL Business Overview
Table 94. MED-EL Artificial Organs and Bionic Implants Product
Table 95. MED-EL Revenue in Artificial Organs and Bionic Implants Business (2018-2023) & (US$ Million)
Table 96. MED-EL Recent Development
Table 97. Toray Medical Company Detail
Table 98. Toray Medical Business Overview
Table 99. Toray Medical Artificial Organs and Bionic Implants Product
Table 100. Toray Medical Revenue in Artificial Organs and Bionic Implants Business (2018-2023) & (US$ Million)
Table 101. Toray Medical Recent Development
Table 102. Sonova Company Detail
Table 103. Sonova Business Overview
Table 104. Sonova Artificial Organs and Bionic Implants Product
Table 105. Sonova Revenue in Artificial Organs and Bionic Implants Business (2018-2023) & (US$ Million)
Table 106. Sonova Recent Development
Table 107. Medtronic Company Detail
Table 108. Medtronic Business Overview
Table 109. Medtronic Artificial Organs and Bionic Implants Product
Table 110. Medtronic Revenue in Artificial Organs and Bionic Implants Business (2018-2023) & (US$ Million)
Table 111. Medtronic Recent Development
Table 112. Getinge (Maquet) Company Detail
Table 113. Getinge (Maquet) Business Overview
Table 114. Getinge (Maquet) Artificial Organs and Bionic Implants Product
Table 115. Getinge (Maquet) Revenue in Artificial Organs and Bionic Implants Business (2018-2023) & (US$ Million)
Table 116. Getinge (Maquet) Recent Development
Table 117. William Demant Company Detail
Table 118. William Demant Business Overview
Table 119. William Demant Artificial Organs and Bionic Implants Product
Table 120. William Demant Revenue in Artificial Organs and Bionic Implants Business (2018-2023) & (US$ Million)
Table 121. William Demant Recent Development
Table 122. LivaNova (Sorin) Company Detail
Table 123. LivaNova (Sorin) Business Overview
Table 124. LivaNova (Sorin) Artificial Organs and Bionic Implants Product
Table 125. LivaNova (Sorin) Revenue in Artificial Organs and Bionic Implants Business (2018-2023) & (US$ Million)
Table 126. LivaNova (Sorin) Recent Development
Table 127. Terumo Company Detail
Table 128. Terumo Business Overview
Table 129. Terumo Artificial Organs and Bionic Implants Product
Table 130. Terumo Revenue in Artificial Organs and Bionic Implants Business (2018-2023) & (US$ Million)
Table 131. Terumo Recent Development
Table 132. Hangzhou Nurotron Company Detail
Table 133. Hangzhou Nurotron Business Overview
Table 134. Hangzhou Nurotron Artificial Organs and Bionic Implants Product
Table 135. Hangzhou Nurotron Revenue in Artificial Organs and Bionic Implants Business (2018-2023) & (US$ Million)
Table 136. Hangzhou Nurotron Recent Development
Table 137. Syncardia Company Detail
Table 138. Syncardia Business Overview
Table 139. Syncardia Artificial Organs and Bionic Implants Product
Table 140. Syncardia Revenue in Artificial Organs and Bionic Implants Business (2018-2023) & (US$ Million)
Table 141. Syncardia Recent Development
Table 142. CorWave Company Detail
Table 143. CorWave Business Overview
Table 144. CorWave Artificial Organs and Bionic Implants Product
Table 145. CorWave Revenue in Artificial Organs and Bionic Implants Business (2018-2023) & (US$ Million)
Table 146. CorWave Recent Development
Table 147. Listent Medical Company Detail
Table 148. Listent Medical Business Overview
Table 149. Listent Medical Artificial Organs and Bionic Implants Product
Table 150. Listent Medical Revenue in Artificial Organs and Bionic Implants Business (2018-2023) & (US$ Million)
Table 151. Listent Medical Recent Development
Table 152. Evaheart Company Detail
Table 153. Evaheart Business Overview
Table 154. Evaheart Artificial Organs and Bionic Implants Product
Table 155. Evaheart Revenue in Artificial Organs and Bionic Implants Business (2018-2023) & (US$ Million)
Table 156. Evaheart Recent Development
Table 157. Open Bionics Company Detail
Table 158. Open Bionics Business Overview
Table 159. Open Bionics Artificial Organs and Bionic Implants Product
Table 160. Open Bionics Revenue in Artificial Organs and Bionic Implants Business (2018-2023) & (US$ Million)
Table 161. Open Bionics Recent Development
Table 162. OYMotion Technologies Company Detail
Table 163. OYMotion Technologies Business Overview
Table 164. OYMotion Technologies Artificial Organs and Bionic Implants Product
Table 165. OYMotion Technologies Revenue in Artificial Organs and Bionic Implants Business (2018-2023) & (US$ Million)
Table 166. OYMotion Technologies Recent Development
Table 167. Mobius Bionics Company Detail
Table 168. Mobius Bionics Business Overview
Table 169. Mobius Bionics Artificial Organs and Bionic Implants Product
Table 170. Mobius Bionics Revenue in Artificial Organs and Bionic Implants Business (2018-2023) & (US$ Million)
Table 171. Mobius Bionics Recent Development
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Artificial Organs and Bionic Implants Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Artificial Organs and Bionic Implants Market Share by Type: 2022 VS 2029
Figure 3. Artificial Kidney Features
Figure 4. Artificial Heart & Ventricular Assist Device Features
Figure 5. Cochlear Implant Features
Figure 6. Artificial Lung Features
Figure 7. Artificial Liver Features
Figure 8. Artificial Pancreas Features
Figure 9. Bionic Hands & Prosthetics Features
Figure 10. Others Features
Figure 11. Global Artificial Organs and Bionic Implants Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 12. Global Artificial Organs and Bionic Implants Market Share by Application: 2022 VS 2029
Figure 13. Commercialize Case Studies
Figure 14. Clinical Research Case Studies
Figure 15. Artificial Organs and Bionic Implants Report Years Considered
Figure 16. Global Artificial Organs and Bionic Implants Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 17. Global Artificial Organs and Bionic Implants Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Artificial Organs and Bionic Implants Market Share by Region: 2022 VS 2029
Figure 19. Global Artificial Organs and Bionic Implants Market Share by Players in 2022
Figure 20. Global Top Artificial Organs and Bionic Implants Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Organs and Bionic Implants as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Artificial Organs and Bionic Implants Revenue in 2022
Figure 22. North America Artificial Organs and Bionic Implants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. North America Artificial Organs and Bionic Implants Market Share by Country (2018-2029)
Figure 24. United States Artificial Organs and Bionic Implants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Artificial Organs and Bionic Implants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Artificial Organs and Bionic Implants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Artificial Organs and Bionic Implants Market Share by Country (2018-2029)
Figure 28. Germany Artificial Organs and Bionic Implants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Artificial Organs and Bionic Implants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Artificial Organs and Bionic Implants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Artificial Organs and Bionic Implants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Artificial Organs and Bionic Implants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Artificial Organs and Bionic Implants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Artificial Organs and Bionic Implants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Artificial Organs and Bionic Implants Market Share by Region (2018-2029)
Figure 36. China Artificial Organs and Bionic Implants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Japan Artificial Organs and Bionic Implants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. South Korea Artificial Organs and Bionic Implants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Southeast Asia Artificial Organs and Bionic Implants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. India Artificial Organs and Bionic Implants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Australia Artificial Organs and Bionic Implants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Artificial Organs and Bionic Implants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Artificial Organs and Bionic Implants Market Share by Country (2018-2029)
Figure 44. Mexico Artificial Organs and Bionic Implants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Brazil Artificial Organs and Bionic Implants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Artificial Organs and Bionic Implants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Artificial Organs and Bionic Implants Market Share by Country (2018-2029)
Figure 48. Turkey Artificial Organs and Bionic Implants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Artificial Organs and Bionic Implants Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Fresenius Medical Care Revenue Growth Rate in Artificial Organs and Bionic Implants Business (2018-2023)
Figure 51. Cochlear Revenue Growth Rate in Artificial Organs and Bionic Implants Business (2018-2023)
Figure 52. Abiomed Revenue Growth Rate in Artificial Organs and Bionic Implants Business (2018-2023)
Figure 53. ABBOTT Revenue Growth Rate in Artificial Organs and Bionic Implants Business (2018-2023)
Figure 54. Baxter Revenue Growth Rate in Artificial Organs and Bionic Implants Business (2018-2023)
Figure 55. B.Braun Revenue Growth Rate in Artificial Organs and Bionic Implants Business (2018-2023)
Figure 56. Asahi Kasei Corporation Revenue Growth Rate in Artificial Organs and Bionic Implants Business (2018-2023)
Figure 57. Nipro Revenue Growth Rate in Artificial Organs and Bionic Implants Business (2018-2023)
Figure 58. MED-EL Revenue Growth Rate in Artificial Organs and Bionic Implants Business (2018-2023)
Figure 59. Toray Medical Revenue Growth Rate in Artificial Organs and Bionic Implants Business (2018-2023)
Figure 60. Sonova Revenue Growth Rate in Artificial Organs and Bionic Implants Business (2018-2023)
Figure 61. Medtronic Revenue Growth Rate in Artificial Organs and Bionic Implants Business (2018-2023)
Figure 62. Getinge (Maquet) Revenue Growth Rate in Artificial Organs and Bionic Implants Business (2018-2023)
Figure 63. William Demant Revenue Growth Rate in Artificial Organs and Bionic Implants Business (2018-2023)
Figure 64. LivaNova (Sorin) Revenue Growth Rate in Artificial Organs and Bionic Implants Business (2018-2023)
Figure 65. Terumo Revenue Growth Rate in Artificial Organs and Bionic Implants Business (2018-2023)
Figure 66. Hangzhou Nurotron Revenue Growth Rate in Artificial Organs and Bionic Implants Business (2018-2023)
Figure 67. Syncardia Revenue Growth Rate in Artificial Organs and Bionic Implants Business (2018-2023)
Figure 68. CorWave Revenue Growth Rate in Artificial Organs and Bionic Implants Business (2018-2023)
Figure 69. Listent Medical Revenue Growth Rate in Artificial Organs and Bionic Implants Business (2018-2023)
Figure 70. Evaheart Revenue Growth Rate in Artificial Organs and Bionic Implants Business (2018-2023)
Figure 71. Open Bionics Revenue Growth Rate in Artificial Organs and Bionic Implants Business (2018-2023)
Figure 72. OYMotion Technologies Revenue Growth Rate in Artificial Organs and Bionic Implants Business (2018-2023)
Figure 73. Mobius Bionics Revenue Growth Rate in Artificial Organs and Bionic Implants Business (2018-2023)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(QYR23MA7636 )"人工臓器&バイオニックインプラントの世界市場2023年:人工腎臓、人工心臓&補助人工心臓、人工内耳、人工肺、人工肝臓、人工膵臓、バイオニックハンド&人工装具、その他" (英文:Global Artificial Organs and Bionic Implants Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。